biotechNew
Recursion Pharmaceuticals
AI-native biotech mapping biology at industrial scale.
weight 0.0PaidLaunched 2026-06-07
💸 No earnings reported yet
What it is
The largest AI-native biotech by headcount, combining automated wet-lab experiments with machine learning across one of the sector's broadest drug pipelines following its Exscientia merger.
How AI plugs in
Machine-learning models trained on petabytes of in-house automated-lab cell imagery map phenotypes to compounds, letting the platform predict drug effects across a vast chemical space.
★ Reviews
No reviews yet — be the first.Your rating